M&A Deal Summary

MDxHealth Acquires Exact Sciences - DX GPS Prostate Cancer Business

On August 2, 2022, MDxHealth acquired life science company Exact Sciences - DX GPS Prostate Cancer Business from Exact Sciences for 100M USD

Acquisition Highlights
  • This is MDxHealth’s 2nd transaction in the Life Science sector.
  • This is MDxHealth’s largest (disclosed) transaction.
  • This is MDxHealth’s 1st transaction in the United States.
  • This is MDxHealth’s 1st transaction in Wisconsin.

M&A Deal Summary
Date 2022-08-02
Target Exact Sciences - DX GPS Prostate Cancer Business
Sector Life Science
Buyer(s) MDxHealth
Sellers(s) Exact Sciences
Deal Type Divestiture
Deal Value 100M USD

Target

Exact Sciences - DX GPS Prostate Cancer Business

Madison, Wisconsin, United States
Exact Sciences's DX GPS Prostate Cancer Business is a broadly commercialized and clinically validated test available today across the urology community. Exact Sciences's DX GPS Prostate Cancer Business is based in Madison, Wisconsin.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

MDxHealth

Herstal, Belgium
Category Company
Founded 2003
Sector Life Science
Employees300
Revenue 70M USD (2023)
DESCRIPTION

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. MDxHealth was founded in 2003 and is based in Herstal, Belgium.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Divestiture) 1 of 1
State (Wisconsin) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-18 NovioGendix Holding BV

Nijmegen, Netherlands

NovioGendix Holding BV is a molecular diagnostic research and service company providing an expert-based, integrated approach in developing advanced and clinically useful molecular diagnostic assays for the uro-oncological practice.

Buy -

Seller(S) 1

SELLER

Exact Sciences

Madison, Wisconsin, United States
Category Company
Founded 1995
Sector Life Science
Employees6,500
Revenue 2.5B USD (2023)
DESCRIPTION

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Wisconsin) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-09 PreventionGenetics

Marshfield, Wisconsin, United States

PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. PreventionGenetics was founded in 2004 and is based in Marshfield, Wisconsin.

Buy $190M
Mergr

Product

Company

Legal